New York, NY -- (SBWIRE) -- 12/17/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Huntington Bancshares Incorporated (NASDAQ:HBAN), FuelCell Energy Inc (NASDAQ:FCEL), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Frontier Communications Corp (NASDAQ:FTR)
Huntington Bancshares Incorporated (NASDAQ:HBAN) showed a volume of 7.88 million shares by the end of last trade whereas the average volume of the stock remained 9.46 million shares. The stock opened the session at $9.43but then moved to $9.51. At that price, the stock showed a positive performance of 0.53%. Huntington Bancshares Incorporated (Huntington) is a multi-state diversified regional bank holding company. Through its subsidiaries, including its bank subsidiary, The Huntington National Bank (the Bank), Huntington is engaged in providing full-service commercial, small business, consumer banking services, mortgage banking services, automobile financing, equipment leasing,
Will HBAN Continue To Move Higher? Find Out Here
FuelCell Energy Inc (NASDAQ:FCEL) opened the session at $1.89 and closed the session at $1.86. Traded with volume of 7.79 million shares in the prior session and the average volume of the stock remained 3.87 million shares. FuelCell Energy, Inc. (FuelCell Energy) is a integrated fuel cell company. The Company designs, manufactures, sells, installs, operates and service ultra-clean, stationary fuel cell power plants for distributed baseload power generation.
Is FCEL a Solid Investment at These Levels? Read This Report For Details
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) opened the session at $0.99 and closed the session at $0.902. The stock showed a negative performance of -11.57% in previous trading session. The beta of the stock remained 2.71. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens,
Why Should Investors Buy IMUC After the Recent Fall? Just Go Here and Find Out
Frontier Communications Corp (NASDAQ:FTR) traded with volume of 7.19 million shares in the prior session and the average volume of the stock remained 10.47 million shares. The beta of the stock remained 0.70. Frontier Communications Corporation (Frontier) is a communications company providing services primarily to rural areas and small and medium-sized towns and cities in the United States.The Company offers a range of voice, data, Internet, and television services and products, some that are available a la carte, and others that are available as bundled or packaged solutions. It operated in 27 states, and was the Incumbent Local Exchange Carrier (ILEC),
Is FTR a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)